Leading trade associations representing the dietary supplements industry will host an all-day Dietary Supplements Seminar in North Bethesda, MD, on May 10, featuring U.S. Food and Drug Administration (FDA) officials along with industry regulatory experts to discuss the key regulatory compliance issues facing the industry.
 
The seminar represents a collaboration by the Consumer Healthcare Products Association (CHPA), the Council for Responsible Nutrition (CRN), the American Herbal Products Association (AHPA), and the United Natural Products Alliance (UNPA) aimed at convening stakeholders from across the dietary supplement sector to discuss issues, trends, and opportunities for collaboration.  

Of note, at the seminar, FDA officials will provide an update on frequently asked questions regarding changes to nutrition and supplement facts labels and discuss adverse event handling processes. A closing panel featuring Steve Tave, FDA’s director in the Office of Dietary Supplement Programs (ODSP) and senior leaders from the dietary supplement trade associations will discuss priorities facing the sector as well as opportunities for collaboration. The seminar will be moderated by industry veteran Scott Bass, who heads Sidley Austin’s Global Life Sciences team. This seminar is open to all. Click here to register and to see event details.
 
The agenda from 10 a.m. to 5 p.m. includes:
 
Opening Remarks
Scott Melville, president and CEO, CHPA

Elements of a Successful New Dietary Ingredient Notification (NDIN)
Ryan Simon, associate director, toxicology & regulatory affairs, Intertek

FDA Analysis of Trends in New Dietary Ingredient Notifications from Industry
Cara Welch, acting director, ODSP, FDA
 
FDA Update on Adverse Event Report Handling Process and Suggestions for Improvement
Lyle Canida, branch chief, FDA

FSMA Implementation
Allen Sayler, EAS senior director for food and cosmetic consulting services, EAS Consulting Group

FDA Update on Frequently Asked Questions Regarding Changes to Nutrition and Supplement Facts Labels
FDA speaker, TBD
 
FDA and Industry Session on GMP Inspections
Angela Pope, consumer safety officer, FDA
 
Process for Issuing and Reviewing Hold Notices
FDA speaker, TBD
 
How to Respond to FDA Hold Notices
Ricardo Carvajal, director, Hyman, Phelps & McNamara
 
FDA and Industry Update on Priorities and Opportunities for Collaboration
Steve Tave, director, ODSP, CFSAN, FDA; and senior leaders of the dietary supplement trade associations